Harvard’s David Sinclair treats aging as a disease and plans to launch a clinical trial to prove it
David Sinclair of Harvard University, renowned for his research on anti-aging, believes that there is no limit to human life expectancy. He has collaborated on a trial to determine the effectiveness of a drug designed to slow down the aging process.
Sinclair, Ph.D. explains that there is no such thing as a maximum life expectancy for humans. He is a professor at the Department of Genetics, and the co-director of the Paul F. Glenn Center for the Biology of Aging, both located at Harvard Medical School. Anyone who says this doesn’t understand what they are saying.
Sinclair wants to show that what he’s been researching and discussing for the last 20 years is true: aging can be treated.
Source:
https://wxpress.wuxiapptec.com/harvards-david-sinclair-treats-aging-disease-plans-launch-clinical-trial-prove/
